Skip to content

Clinical trials

Phase 2 Myelodysplastic Syndromes trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myelodysplastic Syndromes Phase: Phase 2 Country / region: Israel Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20081
20112
20121
20151
20162
20181
20201
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Withdrawn3
Unknown status2
Terminated1
Suspended1
Recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sheba Medical Center2
Tel-Aviv Sourasky Medical Center2
Agios Pharmaceuticals, Inc.1
BioMAS Ltd1
Cellphire Therapeutics, Inc.1
Dr. Avichai Shimoni MD1
Hadassah Medical Organization1
Immune System Key Ltd1
Keros Therapeutics, Inc.1
Millennium Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myelodysplastic Syndromes14
Leukemia, Myeloid, Acute6
Myeloproliferative Disorders2
Primary Myelofibrosis2
Thrombocytopenia2
Anemia1
Anemia, Aplastic1
Anemia, Iron-Deficiency1
Cytopenia1
Hematologic Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.